Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of purified inactivated Japanese encephalitis vaccine (Vero cells) in healthy infants
ChiCTR2300074692Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Japanese encephalitis inactivated vaccine (Vero cells) in Japanese encephalitis (JE) (3 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoint: Positive conversion rate of serum Japanese encephalitis neutralizing antibody. Started Oct 2014; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine (Vero cells)
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on ChiCTR2300074692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074692.